Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates

Cancer Research

Volumn 62, Issue 6, 2002, Pages 1624-1631

  Liou, Jieh Yuan ^a   Dutschman, Ginger E ^a   Lam, Wing ^a   Jiang, Zaoli ^a   Cheng, Yung Chi ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID; ARABINOFURANOSYLCYTIDINE PHOSPHATE; BETA DEXTRO 2',3' DIDEOXYCYTIDINE PHOSPHATE; BETA LEVO 2',3' DIDEOXY 2',3' DIDEHYDRO 5 FLUOROCYTIDINE PHOSPHATE; BETA LEVO 2',3' DIDEOXY 3' THIACYTIDINE PHOSPHATE; BETA LEVO 2',3' DIDEOXY 5 FLUORO 3' THIACYTIDINE PHOSPHATE; BETA LEVO 2',3' DIDEOXYCYTIDINE PHOSPHATE; BETA LEVO DIOXOLANECYTIDINE PHOSPHATE; CYTIDINE DERIVATIVE; CYTIDINE DIPHOSPHATE; CYTIDINE PHOSPHATE; CYTIDINE TRIPHOSPHATE; DEOXYADENOSINE TRIPHOSPHATE; DEOXYCYTIDINE PHOSPHATE; DITHIOTHREITOL; GEMCITABINE; MERCAPTOETHANOL; NUCLEOSIDE DERIVATIVE; PHOSPHOTRANSFERASE; RNA; THIOREDOXIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE PHOSPHATE;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; GENE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OXIDATION REDUCTION POTENTIAL; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTIBODY SPECIFICITY; CLONING, MOLECULAR; CYTIDINE MONOPHOSPHATE; DEOXYCYTIDINE; ESCHERICHIA COLI; GENE EXPRESSION; HELA CELLS; HUMANS; KB CELLS; NUCLEOSIDE-PHOSPHATE KINASE; PHOSPHORYLATION; PYRIMIDINES; RECOMBINANT PROTEINS; STEREOISOMERISM; SUBCELLULAR FRACTIONS;

EID: 0037086275     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Metabolism of deoxyribonucleotides. I. Purification and properties of deoxycytidine monophosphokinase of calf thymus
2. Primary structure of the S. cerevisiae gene encoding uridine monophosphokinase
3. cDNA-derived sequence of UMP-CMP kinase from Dictyostelium discoideum and expression of the enzyme in Escherichia coli
4. Pyrimidine nucleoside monophosphate kinase isolated from pig brain homogenate catalyzes disproportionation of phosphate between two CDP molecules
5. Characteristics, substrate analysis, and intracellular location of Saccharomyces cerevisiae UMP kinase
6. Cloning, sequencing, and expression in Escherichia coli of cDNA encoding porcine brain UMP-CMP kinase
7. CMP kinase from Escherichia coli is structurally related to other nucleoside monophosphate kinases
8. Cloning and heterologous expression of Entamoeba histolytica adenylate kinase and uridylate/cytidylate kinase
9. Cloning, expression in Escherichia coli, and characterization of Arabidopsis thaliana UMP/CMP kinase
10. Genetic characterization and isolation of the Saccharomyces cerevisiae gene coding for uridine monophosphokinase
11. Pyrimidine and purine antimetabolites
12. Metabolism, toxicity, and anti-HIV activity of 2′-deoxy-3′-thia-cytidine (BCH- 189) in T and B cell lines
13. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues
14. Activities of the four optical isomers of 2′,3′-dideoxy-3′-thiacytidine (BCH-189) against human immunodeficiency virus type I in human lymphocytes
15. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
16. Deoxycytidine deaminase-resistant stereoisomer is the active form of (±)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication
17. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel
18. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks
19. Use of novel β-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma
20. Antihepatitis B virus activity and metabolism of 2′,3′-dideoxy-2′,3′-didehydro-β -L(-)-5-fluorocytidine
21. Characterization of the antiviral effect of 2′.3′-dideoxy-2′, 3′-didehydro-β-L-5-fluorocytidine in the duck hepatitis B virus infection model
22. Antiviral activity of β-L-2′,3′-dideoxy-2′,3′-didehydro-5- fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus
23. Uptake and metabolism of the new anticancer compound β-L-(-)-dioxolane-cytidine in human prostate carcinoma DU-145 cells
24. Anticancer activity of βL-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration
25. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (β-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models
26. Preclinical pharmacokinetics of β-L-dioxolane-cytidine, a novel anticancer agent, in rats
27. The new dioxolane, (-)-2′-deoxy-3′-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts
28. A Phase I and pharmacokinetic (PK) study of the L-nucleoside analog, Troxacitabine (BCH-4556) with cisplatin-associated reduction of Troxacitabine clearance
29. Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia
30. Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases
31. A pyrimidine nucleoside monophosphate kinase from rat liver
32. Differences between pyrimidine nucleoside monophosphate kinase from rat Novikoff ascites hepatoma and rat liver
33. Human erythrocyte pyrimidine nucleoside monophosphate kinase. Partial purification and properties of two allelic gene products
34. A new deoxyuridine-5′-triphosphatase in Yoshida sarcoma cells involved in deoxyuridine 5′-triphosphate metabolism
35. Pyrimidine nucleoside monophosphate kinase from human leukemic blast cells
36. Kinetics and equilibria of pyrimidine nucleoside monophosphate kinase from human erythrocytes
37. The role of deoxyuridine triphosphate nucleotidohydrolase, uracil-DNA glycosylase, and DNA polymerase α in the metabolism of FUdR in human tumor cells
38. Pyrimidine nucleoside monophosphate kinase from rat bone marrow cells: Purification to high specific activity by a two-step affinity chromatography procedure
39. Pyrimidine nucleoside monophosphate kinase from rat bone marrow cells: Chromatographic, electrophoretic, and sedimentation behavior of active and inactive enzyme forms
40. Pyrimidine nucleoside monophosphate kinase from rat bone marrow cells: A kinetic analysis of the reaction mechanism
41. Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: Molecular characterization of the human enzyme
42. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
43. A new rapid assay for measuring deoxycytidylate- and deoxythymidylate-kinase activities
44. A new technique for the assay of infectivity of human adenovirus 5 DNA
45. Human deoxycytidine kinase: Kinetic mechanism and end product regulation
46. Kinetic properties and inhibition of human T lymphoblast deoxycytidine kinase
47. Intracellular distribution of various enzymes concerned with DNA synthesis from normal and regenerating rat liver and Yoshida sarcoma
48. Characterization of a dCTP transport activity reconstituted from human mitochondria
49. Physiological concentrations of purines and pyrimidines